Jacobson Research & Pharmaceutical (2633.HK): FY20 Results Summary
銀河國際Jul 15, 2020 00:00
Jacobson Research & Pharmaceutical (2633.HK): Recurring net profit increased steadily in the middle of fiscal year 20
銀河國際Nov 27, 2019 00:00
Jacobson Research Pharmaceuticals (2633.HK): Sustainable Growth Has a New Advantage Perspective for Biopharmaceuticals
國信證券(香港)Jun 28, 2018 00:00
Jacobson Research Pharmaceuticals (2633.HK): Business focus shifts from generic drugs to biosimilar valuation may be boosted
銀河國際Jun 11, 2018 00:00
Puyu Gongjin Gold* Company* Jacobson Research & Pharmaceutical (2633.HK): Proposed issuance of HK$500 million convertible bonds
中銀國際Sep 15, 2017 00:00
Pu Jade Co., Ltd. * Jacob Research Pharmaceuticals (2633.HK): net profit for fiscal year 18 is expected to increase by 45% compared with the same period last year.
中銀國際Jun 30, 2017 00:00
Jacobson Research Pharmaceuticals (2633.HK): Hong Kong's unique generic drug manufacturer aims to achieve rapid growth through acquisitions and mergers
招銀國際Jan 12, 2017 00:00
Deepin* Company* Jacobson Research Pharmaceutical (2633.HK): Acquire a well-known generic drug brand
中銀國際Dec 16, 2016 00:00
Pu Jade Co., Ltd. * Jacobson Research Pharmaceutical (2633.HK): solid performance in the first half of fiscal year 17
中銀國際Nov 29, 2016 00:00
Jacobs Research Pharmaceutical Co., Ltd. (2633.HK) apply for new shares
長雄證券Sep 9, 2016 00:00
Jacobson (2633.HK) IPO Research
羣益證券(香港)Sep 9, 2016 00:00
Short IPO review of Jacosson Pharmaceuticals (2633.HK): Hong Kong's largest generic drug supplier
光大證券Sep 9, 2016 00:00
Jacochen Research Pharmaceuticals Ltd. (2633.HK): IPO Express
致富證券Sep 8, 2016 00:00
Jacochen Research Pharmaceutical Co., Ltd. (02633.HK): Initial Public Sale
時富證券Sep 8, 2016 00:00
No Data
No Data